Dasatinib as First-Line Treatment For Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Blood. 2011 Sept 19;[Epub Ahead of Print], R Foa, A Vitale, M Vignetti, M Baccarani, et al
TAKE-HOME MESSAGE: Results of this phase II study by the GIMEMA group indicate that dasatinib is safe and effective alone, with steroids, as first-line treatment in adult patients, including elderly, with Ph+ acute lymphoblastic leukemia.
http://www.oncologystat.com/journals/journal_scans/Dasatinib_as_First-Line_Treatment_For_Adult_Patients_With_Philadelphia_Chromosome-Positive_Acute_Lymphoblastic_Leukemia.html
